Cue Biopharma, . vs Purple Biotech
Cue Biopharma, . vs Purple Biotech, compared side by side on 14 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Cue Biopharma, . is on 62/100 and Purple Biotech on 20/100.
Where each one leads
Cue Biopharma, .
- our overall score: 62/100 against 20/100
- domain rating: 34/100 against 26/100
- headcount: 38 against 19
- LinkedIn following: 5,297 against 1,430
Purple Biotech
- agent readiness: 50/100 against 42/100
At a glance
| Measure | Cue Biopharma, . | Purple Biotech |
|---|---|---|
| What it is | Developing engineered biologics to harness the immune system for disease treatment. | Clinical-stage company developing novel oncology therapies to overcome tumor immune evasion and drug resistance. |
| Category | Biotech, Drug Discovery, Immunotherapy, Therapeutics | Biotech, Life Sciences, Drug Discovery, Clinical Trials |
| Sells toBusiness model | B2B | B2B |
| Offering | Biotech | Services |
| Founded | 2017 | 2013 |
| Headquarters | Boston, United States | Tel Aviv, Israel |
| Status | Active | Active |
Size, funding and growth
| Measure | Cue Biopharma, . | Purple Biotech |
|---|---|---|
| Employees | 38 | 19 |
| Total funding | $10.0M | Not published |
| Latest round | Seed | Bootstrapped |
| LinkedIn followers | 5,297 | 1,430 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Cue Biopharma, . | Purple Biotech |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 62/100 | 20/100 |
| Traction | Not published | 13/100 |
| Team | 60/100 | Not published |
| Search visibility | 67/100 | 25/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (42/100) | D (50/100) |
| Domain ratingLink authority, 0-100 | 34/100 | 26/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Cue Biopharma, . | Purple Biotech |
|---|---|---|
| Hosting | Not detected | Google Cloud |
| CDN | Cloudflare | Not detected |
| CMS | WordPress | Not detected |
| Frameworks | Tailwind CSS | Not detected |
| Analytics | Google Analytics 4 | Not detected |
What users say
| Measure | Cue Biopharma, . | Purple Biotech |
|---|---|---|
| Reddit sentimentThreads we track | Not published | 4 positive, 0 negative across 6 threads |
“Purple Biotech presenta nuevos datos preclínicos en EACR 2026 que destacan la actividad antitumoral de IM1240, su favorable perfil de seguridad y farmacocinético, y su amplio margen terapéutico.”r/biotech_stocks
Cue Biopharma, . vs Purple Biotech: common questions
Which is better, Cue Biopharma, . or Purple Biotech?
On our 0-100 score Cue Biopharma, . rates higher (62/100 against 20/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 14 data points above: read the rows that match what you are buying for.
How do Cue Biopharma, . and Purple Biotech compare on the numbers?
Cue Biopharma, . leads on our overall score (62/100 against 20/100), domain rating (34/100 against 26/100), headcount (38 against 19), LinkedIn following (5,297 against 1,430). Purple Biotech leads on agent readiness (50/100 against 42/100).
What do real users say about Cue Biopharma, . and Purple Biotech?
Purple Biotech: 4 positive and 0 negative mentions across 6 Reddit threads we track, mostly in r/biotech_stocks.
Read the full Cue Biopharma, . review and pricing or the Purple Biotech review and pricing. You can also browse other Cue Biopharma, . alternatives we track.